Cell line-based screening for new anticancer drugs
- 1 January 1994
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Neural Computing in Cancer Drug Development: Predicting Mechanism of ActionScience, 1992
- Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell LinesJNCI Journal of the National Cancer Institute, 1991
- The action of bryostatin on normal human hematopoietic progenitors is mediated by accessory cell release of growth factorsBlood, 1990
- In Defense of Cell-Line ScreeningJNCI Journal of the National Cancer Institute, 1990
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI Journal of the National Cancer Institute, 1990
- Dolastatin 10, a powerful cytostatic peptide derived from a marine animalBiochemical Pharmacology, 1990
- Activation of T-cells by bryostatins: Induction of the IL-2 receptor gene transcription and down-modulation of surface receptorsInternational Journal of Immunopharmacology, 1990
- Display and Analysis of Patterns of Differential Activity of Drugs Against Human Tumor Cell Lines: Development of Mean Graph and COMPARE AlgorithmJNCI Journal of the National Cancer Institute, 1989
- Plant antitumor agents. VI. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifoliaJournal of the American Chemical Society, 1971
- Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2Journal of the American Chemical Society, 1966